Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model

American Journal of Pathology

Volumn 181, Issue 2, 2012, Pages 570-582

  Nakamura, Diane S ^a   Edwards, Andrew K ^a   Virani, Sophia ^a   Thomas, Richard ^a   Tayade, Chandrakant ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 898; ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; CYTOKINE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG HALF LIFE; ENDOMETRIOSIS; ENDOTHELIUM CELL; ENGRAFTMENT; EUTHANASIA; FERTILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MATING; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERITONEAL CAVITY; PREGNANCY; PRIORITY JOURNAL; STEM CELL; SURVIVAL; VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; ESTROUS CYCLE; FEMALE; FERTILITY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; PEPTIDOMIMETICS; REPRODUCTION; STEM CELLS; THROMBOSPONDIN 1;

EID: 84864117566     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.05.010     Document Type: Article

References (48)

1. L.C. Giudice Endometriosis N Engl J Med 362 2010 2389 2398
2. S.E. Bulun Endometriosis N Engl J Med 360 2009 268 279
3. G.D. Adamson, S.H. Kennedy, L. Hummelshoj Creating solutions in endometriosis: global collaboration through the World Endometriosis Research Foundation J Endometriosis 2 2010 3 6
4. A. Asante, R.N. Taylor Endometriosis: the role of neuroangiogenesis Annu Rev Physiol 73 2011 163 182
5. J. Halme, M.G. Hammond, J.F. Hulka, S.G. Raj, L.M. Talbert Retrograde menstruation in healthy women and in patients with endometriosis Obstet Gynecol 64 1984 151 154
6. A.R. Levy, K.M. Osenenko, G. Lozano-Ortega, R. Sambrook, M. Jeddi, S. Belisle, R.L. Reid Economic burden of surgically confirmed endometriosis in Canada J Obstet Gynaecol Can 33 2011 830 837
7. T.Z. Jacobson, J.M. Duffy, D. Barlow, P.R. Koninckx, R. Garry Laparoscopic surgery for pelvic pain associated with endometriosis Cochrane Database Syst Rev 4 2009 CD001300
8. F. Petraglia, D. Hornung, C. Seitz, T. Faustmann, C. Gerlinger, S. Luisi, S. Lazzeri, T. Strowitzki Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment Arch Gynecol Obstet 285 2012 167 173
9. T.M. D'Hooghe, S. Debrock Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons Hum Reprod Update 8 2002 84 88
10. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674
11. C.M. Becker, P. Beaudry, T. Funakoshi, O. Benny, A. Zaslavsky, D. Zurakowski, J. Folkman, R. D'Amato, S. Ryeom Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis Am J Pathol 178 2011 1782 1791
12. T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore, M. Silver, M. Kearne, M. Magner, J.M. Isner Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 1999 221 228
13. C.M. Becker, D.A. Sampson, S.M. Short, K. Javaherian, J. Folkman, R.J. D'Amato Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model Fertil Steril 85 2006 71 77
14. A.G. Ricci, C.N. Olivares, M.A. Bilotas, G.F. Meresman, R.I. Barañao Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis Reprod Sci 18 2011 614 622
15. N. Ferrara, K.J. Hillan, H.P. Gerber, W. Novotny Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat Rev Drug Discov 3 2004 391 400
16. M. Laschke, A. Elitzsch, B. Vollmar, P. Vajkoczy, M. Menger Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions Hum Reprod 21 2006 262 268
17. S.A. Garside, J. Henkin, K.D. Morris, S.M. Norvell, F.H. Thomas, H.M. Fraser A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo Endocrinology 151 2010 5905 5915
18. J.L. Yang, C.P. Zhang, L. Li, L. Huang, S.Y. Ji, C.L. Lu, C.H. Fan, H. Cai, Y. Ren, Z.Y. Hu, F. Gao, Y.X. Liu Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis Endocrinology 151 2010 774 782
19. O.V. Volpert, T. Zaichuk, W. Zhou, F. Reiher, T.A. Ferguson, P.M. Stuart, M. Amin, N.P. Bouck Inducer-stimulated fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor Nat Med 8 2002 349 357
20. J. Greenaway, J. Lawler, R. Moorehead, P. Bornstein, J. LaMarre, J. Petrik Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1) J Cell Physiol 210 2007 807 818
21. N. Campbell, J. Greenaway, J. Henkin, J. Petrik ABT-898 induces tumor regression and prolongs survival in a mouse model of epithelial ovarian cancer Mol Cancer Ther 10 2011 1876 1885
22. M.W. Laschke, C. Giebels, R.M. Nickels, C. Scheuer, M.D. Menger Endothelial progenitor cells contribute to the vascularization of endometriotic lesions Am J Pathol 178 2011 442 450
23. R. Hoekstra, F.Y.F.L. de Vos, F.A.L.M. Eskens, J.A. Gietema, A. van der Gaast, H.J.M. Groen, R.A. Knight, R.A. Carr, R.A. Humerickhouse, J. Verwij, E.G. de Vries Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer J Clin Oncol 23 2005 5188 5197
24. Q. Yang, Y. Tian, S. Liu, R. Zeine, A. Chlenski, H.R. Salwen, J. Henkin, S.L. Cohn Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma Cancer Res 67 2007 1716 1724
25. R. Yap, D. Veliceasa, U. Emmenegger, R.S. Kerbel, L.M. McKay, J. Henkin, O.V. Volpert Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy Clin Cancer Res 11 2005 6678 6685
26. J. Greenaway, J. Henkin, J. Lawler, R. Moorehead, J. Petrik ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer Mol Cancer Ther 8 2009 64 74
27. C.M. Becker, R.J. D'Amato Angiogenesis and antiangiogenic therapy in endometriosis Microvasc Res 74 2007 121 130
28. C.M. Becker, D.A. Sampson, M.A. Rupnick, R.M. Rohan, J.A. Efstathiou, S.M. Short, G.A. Taylor, J. Folkman, R.J. D'Amato Endostatin inhibits the growth of endometriotic lesions but does not affect fertility Fertil Steril 84 Suppl 2 2005 1144 1155
29. L.C. Armstrong, B. Björkblom, K.D. Hankenson, A.W. Siadak, C.E. Stiles, P. Bornstein Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism Mol Biol Cell 13 2002 1893 1905
30. S.M. Short, A. Derrien, R.P. Narsimhan, J. Lawler, D.E. Ingber, B.R. Zetter Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins [Erratum appeared in J Cell Biol 2005, 169:541] J Cell Biol 168 2005 643 653
31. F.A. Scappaticci Mechanisms and future directions for angiogenesis-based cancer therapies J Clin Oncol 20 2002 3906 3927
32. K. Gupta, P. Gupta, R. Wild, S. Ramakrishnan, R.P. Hebbel Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis Angiogenesis 3 1999 147 158
33. P. Carmeliet, R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
34. M.W. Laschke, M.D. Menger In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis Hum Reprod Update 13 2007 331 342
35. G. Bergers, S. Song The role of pericytes in blood-vessel formation and maintenance Neuro Oncol 7 2005 452 464
36. J.S. Isenberg, Y. Jia, J. Fukuyama, C.H. Switzer, D.A. Wink, D.D. Roberts Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake J Biol Chem 282 2007 15404 15415
37. J.S. Isenberg, C. Yu, D.D. Roberts Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells Biochem Pharmacol 75 2008 875 882
38. K.L. Bruner-Tran, A.C. Carvalho-Macedo, A.J. Duleba, M.A. Crispens, K.G. Osteen Experimental endometriosis in immunocompromised mice after adoptive transfer of human leukocytes Fertil Steril 93 2010 2519 2524
39. P.H. Liang, F. Tian, Y. Lu, B. Duan, D.B. Stolz, L.Y. Li Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors Angiogenesis 14 2011 61 68
40. M. Laschke, C. Giebels, M. Menger Vasculogenesis: a new piece of the endometriosis puzzle Hum Reprod Update 17 2011 628 636
41. T. Asahara, A. Kawamoto, H. Masuda Concise review: circulating endothelial progenitor cells for vascular medicine Stem Cells 29 2011 1650 1655
42. G.O. Ahn, J.M. Brown Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature Angiogenesis 12 2009 159 164
43. D. Lyden, K. Hattori, S. Dias, C. Costa, P. Blaikie, L. Butros, A. Chadburn, B. Heissig, W. Marks, L. Witte, Y. Wu, D. Hicklin, Z. Zhu, N.R. Hackett, R.G. Crystal, M.A. Moore, K.A. Hajjar, K. Manova, R. Benezra, S. Rafii Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nat Med 7 2001 1194 1201
44. S. Purhonen, J. Palm, D. Rossi, N. Kaskenpää, I. Rajantie, S. Ylä-Herttuala, K. Alitalo, I.L. Weissman, P. Salven Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth Proc Natl Acad Sci USA 105 2008 6620 6625
45. A. Wickersheim, M. Kerber, L.S. de Miguel, K.H. Plate, M.R. Machein Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors Int J Cancer 125 2009 1771 1777
46. J.E. Bluff, M.W.J. Ferguson, S. O'Kane, G. Ireland Bone marrow-derived endothelial progenitor cells do not contribute significantly to new vessels during incisional wound healing Exp Hematol 35 2007 500 506
47. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 2005 932 936
48. S. Dodin, A. Lemay, R. Maheux, M. Dumont, L. Turcot-Lemay Bone mass in endometriosis patients treated with GnRH agonist implant or danazol Obstet Gynecol 77 1991 410 415